Communication of an Abnormal Metabolic New-Born Screening Result in The Netherlands: The Parental Perspective

Overview

Journal Nutrients

Date 2022 Oct 14

PMID 36235614

Authors

Sietske Haitjema

Charlotte M A Lubout

Justine H M Zijlstra

Bruce H R Wolffenbuttel

Francjan J van Spronsen

Affiliations

Soon will be listed here.

Abstract

In the Netherlands, abnormal New-Born Screening (NBS) results are communicated to parents by the general practitioner (GP). Good communication and consequential trust in professionals is of the utmost importance in the treatment of phenylketonuria (PKU). The aim of this study was to assess parental satisfaction regarding the communication of an abnormal NBS result for PKU in the Netherlands. An email containing the link to a web-based questionnaire was sent by the Dutch PKU Association to their members. Responses to open questions were categorized, data of both open and closed questions were analysed with descriptive statistics and the Chi-Square test using SPSS. Out of 113 parents of a child with PKU (born between 1979 and 2020), 68 stated they were overall unsatisfied with the first communication of the NBS result. Seventy-five parents indicated that wrong or no information about PKU was given. A significant decrease was found in the number of parents being contact by their own GP over the course of 40 years (p < 0.05). More than half of all parents were overall unsatisfied with the first communication of the abnormal NBS result for PKU. Further research on how to optimize communication of an abnormal NBS results is necessary.

Citing Articles

Prevalence and predictors of parental distress at the communication of positivity at newborn screening for metabolic diseases: an Italian longitudinal study.

Bani M, Russo S, Gasperini S, Crescitelli V, Menni F, Furlan F BMJ Paediatr Open. 2024; 8(1).

PMID: 39667953 PMC: 11667425. DOI: 10.1136/bmjpo-2024-003103.

Recent Advances in Phenylketonuria: A Review.

Zuniga Vinueza A Cureus. 2023; 15(6):e40459.

PMID: 37456395 PMC: 10349532. DOI: 10.7759/cureus.40459.

References

Burgard P, Rupp K, Lindner M, Haege G, Rigter T, Weinreich S . Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 2. From screening laboratory results to treatment, follow-up and quality assurance. J Inherit Metab Dis. 2012; 35(4):613-25. DOI: 10.1007/s10545-012-9484-z. View

Almannai M, Marom R, Sutton V . Newborn screening: a review of history, recent advancements, and future perspectives in the era of next generation sequencing. Curr Opin Pediatr. 2016; 28(6):694-699. DOI: 10.1097/MOP.0000000000000414. View

Blom M, Bredius R, Jansen M, Weijman G, Kemper E, Vermont C . Parents' Perspectives and Societal Acceptance of Implementation of Newborn Screening for SCID in the Netherlands. J Clin Immunol. 2020; 41(1):99-108. PMC: 7846522. DOI: 10.1007/s10875-020-00886-4. View

Buist N, Tuerck J . The practitioner's role in newborn screening. Pediatr Clin North Am. 1992; 39(2):199-211. DOI: 10.1016/s0031-3955(16)38291-8. View

Ulph F, Cullinan T, Qureshi N, Kai J . Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screening. Eur J Hum Genet. 2014; 23(4):459-65. PMC: 4666569. DOI: 10.1038/ejhg.2014.126. View

van Spronsen F, Blau N, Harding C, Burlina A, Longo N, Bosch A . Phenylketonuria. Nat Rev Dis Primers. 2021; 7(1):36. PMC: 8591558. DOI: 10.1038/s41572-021-00267-0. View

Brockow I, Nennstiel U . Parents' experience with positive newborn screening results for cystic fibrosis. Eur J Pediatr. 2019; 178(6):803-809. DOI: 10.1007/s00431-019-03343-6. View

Guthrie R . The origin of newborn screening. Screening. 1992; 1:5-15. DOI: 10.1016/0925-6164(92)90025-z. View

Liemburg G, Huijbregts S, Rutsch F, Feldmann R, Jahja R, Weglage J . Metabolic control during the neonatal period in phenylketonuria: associations with childhood IQ. Pediatr Res. 2021; 91(4):874-878. DOI: 10.1038/s41390-021-01728-8. View

10.

Seddon L, Dick K, Carr S, Balfour-Lynn I . Communicating cystic fibrosis newborn screening results to parents. Eur J Pediatr. 2020; 180(4):1313-1316. PMC: 7567649. DOI: 10.1007/s00431-020-03829-8. View

11.

Dos Santos K, Gremigni P, Casu G, Zaia V, Montagna E . Development and validation of The Breaking Bad News Attitudes Scale. BMC Med Educ. 2021; 21(1):196. PMC: 8028222. DOI: 10.1186/s12909-021-02636-5. View

12.

Chudleigh J, Holder P, Moody L, Simpson A, Southern K, Morris S . Process evaluation of co-designed interventions to improve communication of positive newborn bloodspot screening results. BMJ Open. 2021; 11(8):e050773. PMC: 8404436. DOI: 10.1136/bmjopen-2021-050773. View

13.

Landolt M, Ribi K, Laimbacher J, Vollrath M, Gnehm H, Sennhauser F . Posttraumatic stress disorder in parents of children with newly diagnosed type 1 diabetes. J Pediatr Psychol. 2002; 27(7):647-52. DOI: 10.1093/jpepsy/27.7.647. View

14.

Barben J, Chudleigh J . Processing Newborn Bloodspot Screening Results for CF. Int J Neonatal Screen. 2020; 6(2):25. PMC: 7422987. DOI: 10.3390/ijns6020025. View

15.

Chudleigh J, Buckingham S, Dignan J, ODriscoll S, Johnson K, Rees D . Parents' Experiences of Receiving the Initial Positive Newborn Screening (NBS) Result for Cystic Fibrosis and Sickle Cell Disease. J Genet Couns. 2016; 25(6):1215-1226. PMC: 5114338. DOI: 10.1007/s10897-016-9959-4. View

16.

Di Ciommo V, Forcella E, Cotugno G . Living with phenylketonuria from the point of view of children, adolescents, and young adults: a qualitative study. J Dev Behav Pediatr. 2012; 33(3):229-35. DOI: 10.1097/DBP.0b013e3182460d8a. View

17.

Berkey F, Wiedemer J, Vithalani N . Delivering Bad or Life-Altering News. Am Fam Physician. 2018; 98(2):99-104. View

18.

Guthrie R, Susi A . A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. Pediatrics. 1963; 32:338-43. View

19.

Rueegg C, Barben J, Hafen G, Moeller A, Jurca M, Fingerhut R . Newborn screening for cystic fibrosis - The parent perspective. J Cyst Fibros. 2016; 15(4):443-51. DOI: 10.1016/j.jcf.2015.12.003. View

20.

Vockley J, Andersson H, Antshel K, Braverman N, Burton B, Frazier D . Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014; 16(2):188-200. DOI: 10.1038/gim.2013.157. View